 Cell Survival
"Cell Survival" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability.
| Descriptor ID |
D002470
|
| MeSH Number(s) |
G04.299.316
|
| Concept/Terms |
Cell Survival- Cell Survival
- Survival, Cell
- Cell Viability
- Cell Viabilities
- Viabilities, Cell
- Viability, Cell
|
Below are MeSH descriptors whose meaning is more general than "Cell Survival".
Below are MeSH descriptors whose meaning is more specific than "Cell Survival".
This graph shows the total number of publications written about "Cell Survival" by people in this website by year, and whether "Cell Survival" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 0 | 1 | 1 | | 1981 | 0 | 1 | 1 | | 1982 | 0 | 1 | 1 | | 1984 | 0 | 3 | 3 | | 1985 | 1 | 3 | 4 | | 1986 | 0 | 7 | 7 | | 1987 | 0 | 4 | 4 | | 1988 | 0 | 4 | 4 | | 1989 | 0 | 5 | 5 | | 1990 | 0 | 3 | 3 | | 1991 | 3 | 2 | 5 | | 1992 | 1 | 3 | 4 | | 1993 | 0 | 8 | 8 | | 1994 | 0 | 6 | 6 | | 1995 | 1 | 4 | 5 | | 1996 | 1 | 15 | 16 | | 1997 | 0 | 6 | 6 | | 1998 | 0 | 7 | 7 | | 1999 | 0 | 10 | 10 | | 2000 | 1 | 17 | 18 | | 2001 | 1 | 19 | 20 | | 2002 | 3 | 23 | 26 | | 2003 | 0 | 20 | 20 | | 2004 | 4 | 29 | 33 | | 2005 | 2 | 25 | 27 | | 2006 | 2 | 29 | 31 | | 2007 | 0 | 24 | 24 | | 2008 | 1 | 38 | 39 | | 2009 | 6 | 43 | 49 | | 2010 | 2 | 40 | 42 | | 2011 | 2 | 38 | 40 | | 2012 | 0 | 47 | 47 | | 2013 | 0 | 47 | 47 | | 2014 | 1 | 44 | 45 | | 2015 | 0 | 38 | 38 | | 2016 | 0 | 29 | 29 | | 2017 | 0 | 25 | 25 |
To return to the timeline, click here.
Below are the most recent publications written about "Cell Survival" by people in Profiles.
-
Goodson NB, Nahreini J, Randazzo G, Uruena A, Johnson JE, Brzezinski JA. Prdm13 is required for Ebf3+ amacrine cell formation in the retina. Dev Biol. 2018 02 01; 434(1):149-163.
-
Flannery PC, DeSisto JA, Amani V, Venkataraman S, Lemma RT, Prince EW, Donson A, Moroze EE, Hoffman L, Levy JMM, Foreman N, Vibhakar R, Green AL. Preclinical analysis of MTOR complex 1/2 inhibition in diffuse intrinsic pontine glioma. Oncol Rep. 2018 Feb; 39(2):455-464.
-
Foley LS, Fullerton DA, Mares J, Sungelo M, Weyant MJ, Cleveland JC, Reece TB. Erythropoietin's Beta Common Receptor Mediates Neuroprotection in Spinal Cord Neurons. Ann Thorac Surg. 2017 Dec; 104(6):1909-1914.
-
Hodgson SM, McNelles SA, Abdullahu L, Marozas IA, Anseth KS, Adronov A. Reproducible Dendronized PEG Hydrogels via SPAAC Cross-Linking. Biomacromolecules. 2017 Dec 11; 18(12):4054-4059.
-
Jones D, Banerjee A, Berger PZ, Gross A, McNish S, Amdur R, Shanmugam VK. Inherent differences in keratinocyte function in hidradenitis suppurativa: Evidence for the role of IL-22 in disease pathogenesis. Immunol Invest. 2018 Jan; 47(1):57-70.
-
Kumar R, Deep G, Wempe MF, Surek J, Kumar A, Agarwal R, Agarwal C. Procyanidin B2 3,3?-di-O-gallate induces oxidative stress-mediated cell death in prostate cancer cells via inhibiting MAP kinase phosphatase activity and activating ERK1/2 and AMPK. Mol Carcinog. 2018 Jan; 57(1):57-69.
-
Williams MM, Vaught DB, Joly MM, Hicks DJ, Sanchez V, Owens P, Rahman B, Elion DL, Balko JM, Cook RS. ErbB3 drives mammary epithelial survival and differentiation during pregnancy and lactation. Breast Cancer Res. 2017 Sep 08; 19(1):105.
-
Thwe PM, Pelgrom L, Cooper R, Beauchamp S, Reisz JA, D'Alessandro A, Everts B, Amiel E. Cell-Intrinsic Glycogen Metabolism Supports Early Glycolytic Reprogramming Required for Dendritic Cell Immune Responses. Cell Metab. 2017 Sep 05; 26(3):558-567.e5.
-
Lev A, Deihimi S, Shagisultanova E, Xiu J, Lulla AR, Dicker DT, El-Deiry WS. Preclinical rationale for combination of crizotinib with mitomycin C for the treatment of advanced colorectal cancer. Cancer Biol Ther. 2017 Sep 02; 18(9):694-704.
-
Mukherjee N, Lu Y, Almeida A, Lambert K, Shiau CW, Su JC, Luo Y, Fujita M, Robinson WA, Robinson SE, Norris DA, Shellman YG. Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells. Oncotarget. 2017 Jul 18; 8(29):46801-46817.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|